Bird Flu > Bird Flu News > DelSite Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine (PrimeNewswire via Yahoo! Finance)
DelSite Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine (PrimeNewswire via Yahoo! Finance)
IRVING, Texas, Aug. 20, 2008 -- DelSite Inc., today announced DelSite Biotechnologies, Inc., its wholly-owned subsidiary, filed an Investigational New Drug application with the FDA for its lead product candidate GelVac nasal powder H5N1 influenza vaccine.
Entire Avian Flu Pandemic Article - Avian Article Archives